Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call ...

Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its financial results for the second quarter ended June 30,